SMTL ID : 3owj.1

Human CK2 catalytic domain in complex with a pyridocarbazole derivative inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.85 Å

Oligo State

monomer

Ligands

1 x 1EL: 9-hydroxy-5,11-dimethyl-4,6-dihydro-1H-pyrido[4,3-b]carbazol-1-one(Non-covalent)

1EL.1: 12 residues within 4Å: Chain A: L.45, G.46, V.53, V.66, F.113, E.114, H.115, V.116, H.160, M.163, I.174, D.175 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.53, A:V.53, A:V.66, A:F.113, A:I.174 Hydrogen bonds: A:E.114, A:V.116 Water bridges: A:K.68, A:D.175 pi-Stacking: A:H.160

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Prudent, R. et al., Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2. Cancer Res. (2010)

Release Date

2010-12-15

Peptides

CSNK2A1 protein: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

CSNK2A1 protein

Related Entries With Identical Sequence